Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.26 trillion and total revenue of $115.82 billion.
Market Cap
1.26T
Revenue
115.82B
Profits
-36.07B
PE Ratio
n/a
Profit Margin
-31.14%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.93B | -0.40% | 940,522 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 75.86B | 0.57% | 10,290,623 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 73.41B | 0.05% | 614,225 | 15.53B |
| 4 | ARGX | argenx SE | 57.39B | -1.79% | 333,867 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.29B | 0.36% | 1,570,170 | - |
| 6 | ONC | BeOne Medicines AG | 40.71B | -0.20% | 505,214 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.87B | -0.82% | 2,229,482 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.40B | -4.96% | 1,662,569 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.80B | 0.62% | 4,390,001 | 7.53M |
| 10 | BNTX | BioNTech SE | 24.34B | 0.05% | 710,505 | 3.03B |
| 11 | INSM | Insmed Incorporated | 24.27B | 2.33% | 4,136,194 | 1.14B |
| 12 | INCY | Incyte Corporation | 23.37B | -1.57% | 2,173,871 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.32B | 0.58% | 5,436,340 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.30B | 1.14% | 638,384 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.96B | 0.25% | 641,431 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.47B | 0.78% | 1,985,830 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.37B | 0.39% | 5,196,190 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.15B | 0.51% | 2,646,126 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.56B | 1.93% | 985,778 | 830.81M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.47B | 2.73% | 2,614,262 | 1.66B |
| 21 | TWST | Twist Bioscience Corporation | 11.83B | 0.33% | 2,087,800 | 431.80M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.54B | -0.06% | 289,635 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.35B | - | 1,866,663 | 1.22B |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | -2.16% | 2,205,004 | 3.41B |
| 25 | IBRX | ImmunityBio, Inc. | 10.90B | 10.83% | 31,318,768 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.54B | -0.93% | 428,223 | 440.48M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 9.39B | -1.55% | 982,669 | 776.57M |
| 28 | CYTK | Cytokinetics, Incorporated | 9.12B | -0.03% | 2,655,074 | 67.67M |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.07B | -0.93% | 1,497,748 | 669.50M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.06B | 0.63% | 763,555 | 281.99M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 8.93B | -2.48% | 879,420 | 105.00M |
| 32 | PCVX | Vaxcyte, Inc. | 8.40B | 0.77% | 2,404,303 | - |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 8.25B | 3.00% | 459,607 | 7.46M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.22B | 3.63% | 1,237,324 | - |
| 35 | ABVX | ABIVAX Société Anonyme | 8.19B | -2.33% | 644,193 | 5.33M |
| 36 | CAI | Caris Life Sciences, Inc. | 8.00B | -0.18% | 3,204,576 | 989.61M |
| 37 | TGTX | TG Therapeutics, Inc. | 7.70B | 1.25% | 1,661,808 | 799.54M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.24B | -1.05% | 2,321,147 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 6.94B | -0.09% | 1,030,380 | - |
| 40 | IOVA | Iovance Biotherapeutics, Inc. | 6.44B | -0.11% | 11,954,618 | 324.97M |
| 41 | BLTE | Belite Bio, Inc | 6.43B | -2.10% | 184,762 | - |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.39B | -0.62% | 506,507 | 239.92M |
| 43 | LGND | Ligand Pharmaceuticals Incorporated | 6.04B | 0.07% | 179,223 | 290.54M |
| 44 | CGON | CG Oncology, Inc. | 5.97B | -1.42% | 1,548,318 | 6.23M |
| 45 | KOD | Kodiak Sciences Inc. | 5.92B | -4.07% | 2,676,466 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.70B | 1.41% | 1,247,172 | - |
| 47 | ORKA | Oruka Therapeutics, Inc. | 5.60B | 1.32% | 586,391 | - |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.38B | -1.18% | 1,138,594 | 618.07M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.38B | -1.80% | 1,177,292 | - |
| 50 | TVTX | Travere Therapeutics, Inc. | 5.37B | 0.14% | 1,134,893 | 591.33M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.36B | -0.02% | 1,132,394 | 13.39M |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.30B | -1.04% | 901,785 | 1.01B |
| 53 | ERAS | Erasca, Inc. | 5.16B | 1.10% | 3,854,493 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.03B | -0.53% | 1,610,162 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | -0.12% | 760,741 | 1.90M |
| 56 | MANE | Veradermics, Incorporated | 4.88B | -0.39% | 598,333 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.50B | 2.27% | 1,482,415 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.45B | -1.22% | 3,714,394 | 66.17M |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.15B | 2.54% | 2,770,961 | 10.35M |
| 60 | TNGX | Tango Therapeutics, Inc. | 3.92B | -4.95% | 5,253,867 | 53.81M |
| 61 | PBLS | Parabilis Medicines, Inc. | 3.74B | -0.53% | 881,228 | 148.00K |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.68B | -2.34% | 1,944,395 | 7.50M |
| 63 | IDYA | IDEAYA Biosciences, Inc. | 3.60B | -1.19% | 585,755 | 234.13M |
| 64 | LEGN | Legend Biotech Corporation | 3.60B | -3.88% | 2,529,465 | 1.27B |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.58B | -1.59% | 299,606 | 890.79M |
| 66 | CELC | Celcuity Inc. | 3.53B | -4.03% | 1,421,124 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.49B | -1.87% | 6,376,247 | - |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.44B | 1.64% | 1,123,171 | - |
| 69 | ACAD | Acadia Pharmaceuticals Inc. | 3.44B | 0.30% | 2,573,069 | 1.14B |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20B | -3.26% | 1,605,253 | 606.33M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.20B | -2.58% | 1,660,040 | 3.60M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -0.51% | 1,785,430 | 463.98M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.11B | -3.13% | 1,041,904 | 117.00M |
| 74 | PGEN | Precigen, Inc. | 3.06B | 4.02% | 6,363,365 | 85.72M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.84B | -3.92% | 2,545,286 | - |
| 76 | MBX | MBX Biosciences, Inc. | 2.82B | 3.47% | 637,300 | - |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 2.77B | -3.97% | 1,548,826 | 7.12M |
| 78 | ZLAB | Zai Lab Limited | 2.73B | -4.59% | 951,837 | 449.61M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 2.49B | -1.65% | 2,414,004 | 158.00K |
| 80 | IRON | Disc Medicine, Inc. | 2.48B | 1.41% | 684,728 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.45B | 0.45% | 1,498,597 | 156.04M |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -1.50% | 815,509 | 36.77M |
| 83 | IMNM | Immunome, Inc. | 2.37B | 0.05% | 1,178,718 | 4.02M |
| 84 | SLS | SELLAS Life Sciences Group, Inc. | 2.37B | 3.62% | 3,846,017 | - |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 2.31B | 0.18% | 973,576 | 959.90M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | 1.23% | 18,839,887 | 54.86M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 2.16% | 1,515,404 | 71.13M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.19B | -1.84% | 1,620,056 | - |
| 89 | PHVS | Pharvaris N.V. | 2.19B | 0.58% | 591,379 | - |
| 90 | ADMA | ADMA Biologics, Inc. | 2.18B | -2.11% | 2,807,172 | 512.28M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -0.75% | 813,423 | 311.51M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | -0.38% | 928,289 | - |
| 93 | VCEL | Vericel Corporation | 2.06B | 1.80% | 482,544 | 306.30M |
| 94 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.05B | 5.33% | 1,913,688 | 208.78M |
| 95 | ADRX | ADARx Pharmaceuticals, Inc. | 2.05B | -6.60% | 936,952 | 6.13M |
| 96 | URGN | UroGen Pharma Ltd. | 2.02B | 2.10% | 612,344 | 188.73M |
| 97 | TRVI | Trevi Therapeutics, Inc. | 1.98B | -1.90% | 2,080,234 | - |
| 98 | GPCR | Structure Therapeutics Inc. | 1.97B | -4.52% | 1,713,214 | - |
| 99 | BHVN | Biohaven Ltd. | 1.94B | -2.05% | 1,753,081 | - |
| 100 | PVLA | Palvella Therapeutics, Inc. | 1.91B | -0.20% | 348,110 | - |
| 101 | FTRE | Fortrea Holdings Inc. | 1.90B | 3.09% | 1,323,988 | 2.68B |
| 102 | ABSI | Absci Corporation | 1.90B | 2.98% | 3,384,923 | 1.56M |
| 103 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -2.09% | 576,207 | 98.34M |
| 104 | VIR | Vir Biotechnology, Inc. | 1.89B | -1.06% | 2,199,894 | 303.23M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 1.75% | 247,812 | 1.13B |
| 106 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.40% | 2,609,944 | 1.97B |
| 107 | XNCR | Xencor, Inc. | 1.85B | 0.28% | 1,103,742 | 104.97M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 1.27% | 1,770,413 | 1.00M |
| 109 | MESO | Mesoblast Limited | 1.84B | -1.68% | 265,207 | 120.25M |
| 110 | NUVB | Nuvation Bio Inc. | 1.80B | -7.55% | 14,830,274 | 169.90M |
| 111 | ZYME | Zymeworks Inc. | 1.78B | -3.12% | 844,441 | 37.13M |
| 112 | SEPN | Septerna, Inc. | 1.76B | -0.89% | 395,446 | 98.88M |
| 113 | GENB | Generate Biomedicines, Inc. | 1.76B | -0.80% | 1,262,976 | 26.48M |
| 114 | BRVE | Braveheart Bio, Inc. | 1.75B | -0.65% | 462,790 | - |
| 115 | NVAX | Novavax, Inc. | 1.73B | -1.32% | 4,022,956 | 413.80M |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 1.16% | 4,515,007 | 59.51M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.65B | -1.50% | 1,118,738 | 27.59M |
| 118 | QURE | uniQure N.V. | 1.63B | 0.39% | 1,957,279 | 18.67M |
| 119 | GHRS | GH Research PLC | 1.57B | 0.35% | 207,628 | - |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | -3.40% | 2,720,810 | 252.25M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.54B | -2.01% | 259,308 | 20.00M |
| 122 | IMCR | Immunocore Holdings plc | 1.53B | -2.72% | 657,606 | 430.78M |
| 123 | OCUL | Ocular Therapeutix, Inc. | 1.53B | -4.53% | 4,958,194 | 52.06M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.51B | -2.32% | 3,442,893 | 5.49M |
| 125 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | 3.19% | 3,912,490 | 717.00M |
| 126 | NKTR | Nektar Therapeutics | 1.49B | -7.26% | 2,923,413 | 54.59M |
| 127 | INVA | Innoviva, Inc. | 1.48B | -0.24% | 774,704 | 440.00M |
| 128 | MAZE | Maze Therapeutics, Inc. | 1.47B | -0.83% | 633,043 | 20.00M |
| 129 | COAG | Hemab Therapeutics Holdings, Inc. | 1.46B | 0.42% | 354,146 | - |
| 130 | ANAB | AnaptysBio, Inc. | 1.45B | -0.21% | 442,897 | 106.09M |
| 131 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -1.01% | 201,446 | 1.30M |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.40B | -2.76% | 1,047,655 | - |
| 133 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.28% | 519,560 | - |
| 134 | KRSA | Korsana Biosciences, Inc. | 1.39B | -2.28% | 51,664 | - |
| 135 | KARD | Kardigan, Inc. | 1.38B | 3.79% | 524,503 | - |
| 136 | AAPG | Ascentage Pharma Group International | 1.37B | -3.36% | 8,994 | 94.61M |
| 137 | DRTS | Alpha Tau Medical Ltd. | 1.36B | 1.79% | 307,385 | - |
| 138 | OMER | Omeros Corporation | 1.35B | 0.76% | 956,328 | 38.42M |
| 139 | KLRA | Kailera Therapeutics, Inc. | 1.35B | -5.80% | 1,283,518 | - |
| 140 | NBTX | Nanobiotix S.A. | 1.31B | -7.71% | 255,769 | 13.15M |
| 141 | DMRA | Damora Therapeutics, Inc. | 1.27B | 2.08% | 692,887 | - |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | -2.52% | 1,232,083 | - |
| 143 | AVLN | Avalyn Pharma Inc. | 1.25B | 2.59% | 526,198 | - |
| 144 | REPL | Replimune Group, Inc. | 1.23B | -2.83% | 1,309,976 | - |
| 145 | SVRA | Savara Inc. | 1.22B | -4.75% | 2,653,259 | - |
| 146 | MNKD | MannKind Corporation | 1.22B | -3.80% | 4,622,265 | 393.63M |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.19B | -0.78% | 388,884 | - |
| 148 | TRAX | First Tracks Biotherapeutics, Inc. | 1.19B | -1.89% | 1,169,659 | - |
| 149 | BCAX | Bicara Therapeutics Inc. | 1.17B | -3.13% | 763,073 | - |
| 150 | VOR | Vor Biopharma Inc. | 1.11B | 3.49% | 773,270 | - |
| 151 | LTGO | Latigo Biotherapeutics, Inc. | 1.05B | -4.73% | 276,566 | - |
| 152 | IMTX | Immatics N.V. | 1.04B | -10.07% | 1,256,935 | 47.65M |
| 153 | MGTX | MeiraGTx Holdings plc | 1.04B | 1.27% | 820,033 | 397.50M |
| 154 | JANX | Janux Therapeutics, Inc. | 1.04B | -0.18% | 805,264 | 24.00M |
| 155 | AKTS | Aktis Oncology, Inc. | 1.03B | - | 309,889 | 10.06M |
| 156 | CGEM | Cullinan Therapeutics, Inc. | 998.14M | 6.74% | 1,162,036 | - |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 993.11M | 1.49% | 192,502 | 99.00K |
| 158 | SPTX | Seaport Therapeutics, Inc. | 983.89M | -3.01% | 258,622 | - |
| 159 | ANRO | Alto Neuroscience, Inc. | 973.20M | -2.02% | 660,690 | - |
| 160 | ANL | Adlai Nortye Group Ltd. | 971.76M | -4.25% | 77,001 | 18.06M |
| 161 | MLTX | MoonLake Immunotherapeutics | 971.07M | -0.52% | 1,827,969 | - |
| 162 | KURA | Kura Oncology, Inc. | 947.43M | - | 1,899,656 | 77.23M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 916.92M | -0.27% | 1,366,746 | - |
| 164 | JBIO | Jade Biosciences, Inc. | 898.00M | 2.54% | 1,109,790 | - |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 895.79M | -6.75% | 2,214,529 | 28.73M |
| 166 | APMD | Apnimed, Inc. | 895.48M | -4.57% | 681,767 | 115.12M |
| 167 | SLBT | SL Science Holding Limited | 895.32M | -1.88% | 52,272 | 3.27M |
| 168 | ALMS | Alumis Inc. | 886.63M | -4.99% | 2,624,625 | 7.40M |
| 169 | RIGL | Rigel Pharmaceuticals, Inc. | 880.76M | 0.38% | 186,408 | 276.79M |
| 170 | ABUS | Arbutus Biopharma Corporation | 880.42M | -2.41% | 8,993,915 | 181.72M |
| 171 | SANA | Sana Biotechnology, Inc. | 865.15M | - | 3,498,442 | - |
| 172 | HELP | Helus Pharma Inc. | 854.80M | -1.76% | 1,407,686 | - |
| 173 | OBX | Obsidian Therapeutics, Inc. | 839.49M | 2.03% | 228,987 | - |
| 174 | IVA | Inventiva S.A. | 836.35M | 2.89% | 4,886,118 | 2.81M |
| 175 | SGP | SpyGlass Pharma, Inc. | 836.20M | -5.66% | 142,058 | - |
| 176 | ARDX | Ardelyx, Inc. | 832.29M | -1.18% | 4,097,064 | 450.89M |
| 177 | DNA | Ginkgo Bioworks Holdings, Inc. | 831.65M | -1.20% | 2,030,683 | 132.42M |
| 178 | LXRX | Lexicon Pharmaceuticals, Inc. | 809.82M | - | 2,317,699 | 41.47M |
| 179 | AVTX | Avalo Therapeutics, Inc. | 803.91M | 0.27% | 948,519 | 59.00K |
| 180 | IMMX | Immix Biopharma, Inc. | 802.50M | -5.38% | 2,548,030 | - |
| 181 | ANNX | Annexon, Inc. | 794.34M | 1.70% | 4,019,803 | - |
| 182 | ATTO | Attovia Therapeutics, Inc. | 783.83M | -3.49% | 348,656 | 1.80M |
| 183 | CADL | Candel Therapeutics, Inc. | 778.96M | 0.20% | 878,803 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 772.26M | 0.82% | 565,844 | - |
| 185 | GERN | Geron Corporation | 770.97M | -0.83% | 14,796,596 | 204.56M |
| 186 | FDMT | 4D Molecular Therapeutics, Inc. | 755.19M | -1.23% | 1,036,920 | 92.01M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 753.90M | 1.57% | 163,746 | 109.82M |
| 188 | ACHV | Achieve Life Sciences, Inc. | 745.01M | -3.85% | 1,886,190 | - |
| 189 | WVE | Wave Life Sciences, Inc. | 744.84M | -2.58% | 3,745,021 | 65.37M |
| 190 | SLDB | Solid Biosciences Inc. | 734.49M | -1.86% | 1,198,175 | - |
| 191 | FTH | Faeth Therapeutics, Inc. | 732.58M | 0.28% | 187,919 | - |
| 192 | OLMA | Olema Pharmaceuticals, Inc. | 719.67M | -0.54% | 1,071,935 | - |
| 193 | NVCT | Nuvectis Pharma, Inc. | 714.19M | 5.79% | 201,596 | - |
| 194 | OABI | OmniAb, Inc. | 708.05M | -2.40% | 1,623,646 | 38.46M |
| 195 | VSTM | Verastem, Inc. | 697.34M | -2.53% | 4,071,836 | 87.53M |
| 196 | PHAR | Pharming Group N.V. | 693.20M | -2.01% | 12,408 | 366.48M |
| 197 | STTK | Shattuck Labs, Inc. | 675.44M | -1.61% | 1,843,743 | 1.00M |
| 198 | MDXG | MiMedx Group, Inc. | 669.04M | -1.08% | 1,374,096 | 355.17M |
| 199 | ETRA | Electra Therapeutics, Inc. | 649.64M | -3.09% | 696,550 | - |
| 200 | SGMT | Sagimet Biosciences Inc. | 648.11M | -2.45% | 1,712,551 | - |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 646.20M | -0.45% | 6,208,845 | 8.22M |
| 202 | SLN | Silence Therapeutics plc | 640.63M | -0.65% | 973,278 | 615.00K |
| 203 | DBVT | DBV Technologies S.A. | 634.13M | -5.89% | 673,300 | 5.04M |
| 204 | AURA | Aura Biosciences, Inc. | 631.56M | 0.83% | 2,099,065 | - |
| 205 | CLYM | Climb Bio, Inc. | 628.35M | -1.17% | 1,574,941 | - |
| 206 | BLSM | BlossomHill Therapeutics, Inc. | 625.84M | 5.92% | 169,325 | - |
| 207 | CBIO | Crescent Biopharma, Inc. | 612.91M | 0.42% | 283,271 | 11.88M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 593.24M | -1.87% | 951,869 | 136.07M |
| 209 | YDES | YD Bio Limited | 574.44M | 3.84% | 546,509 | 1.24M |
| 210 | CRMD | CorMedix Inc. | 560.42M | -3.10% | 1,125,330 | 462.25M |
| 211 | CTMX | CytomX Therapeutics, Inc. | 557.82M | -2.66% | 2,687,320 | 18.30M |
| 212 | PHAT | Phathom Pharmaceuticals, Inc. | 549.66M | -2.26% | 1,683,807 | 239.66M |
| 213 | MPLT | MapLight Therapeutics, Inc. | 545.75M | 1.97% | 565,701 | - |
| 214 | VALN | Valneva SE | 540.23M | -2.71% | 39,844 | 163.30M |
| 215 | OCS | Oculis Holding AG | 538.92M | -0.34% | 586,301 | 1.45M |
| 216 | ALT | Altimmune, Inc. | 532.01M | -0.91% | 4,252,719 | 31.00K |
| 217 | PRME | Prime Medicine, Inc. | 530.15M | -0.33% | 2,108,954 | 4.07M |
| 218 | MNPR | Monopar Therapeutics Inc. | 523.35M | - | 107,621 | - |
| 219 | CAPR | Capricor Therapeutics, Inc. | 520.34M | 0.11% | 2,638,976 | 11.13M |
| 220 | PROK | ProKidney Corp. | 519.99M | 0.58% | 1,089,588 | 818.00K |
| 221 | ALLO | Allogene Therapeutics, Inc. | 518.24M | -2.60% | 4,656,621 | 4.64M |
| 222 | NGNE | Neurogene Inc. | 513.29M | -3.39% | 401,634 | 925.00K |
| 223 | ENTX | Entera Bio Ltd. | 495.19M | -1.04% | 100,694 | 42.00K |
| 224 | CTNM | Contineum Therapeutics, Inc. | 493.59M | 1.00% | 767,942 | - |
| 225 | PBYI | Puma Biotechnology, Inc. | 490.91M | -3.35% | 454,749 | 231.24M |
| 226 | RGNX | REGENXBIO Inc. | 490.48M | 0.13% | 1,045,758 | 174.48M |
| 227 | DRUG | Bright Minds Biosciences Inc. | 488.45M | 3.01% | 154,897 | - |
| 228 | ARVN | Arvinas, Inc. | 484.51M | -0.27% | 585,120 | 316.70M |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 477.13M | -7.54% | 1,714,350 | - |
| 230 | AUTL | Autolus Therapeutics plc | 473.77M | -3.78% | 1,811,772 | 117.39M |
| 231 | OVID | Ovid Therapeutics Inc. | 464.81M | -2.06% | 2,173,632 | 1.58M |
| 232 | ASMB | Assembly Biosciences, Inc. | 458.93M | -1.91% | 368,312 | 74.85M |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 443.81M | -1.44% | 335,678 | - |
| 234 | TECX | Tectonic Therapeutic, Inc. | 440.64M | -0.57% | 233,423 | - |
| 235 | PRTA | Prothena Corporation plc | 429.18M | -2.11% | 675,817 | 54.53M |
| 236 | AGMB | AgomAb Therapeutics NV | 421.56M | -1.04% | 391,112 | - |
| 237 | RZLT | Rezolute, Inc. | 420.64M | -1.47% | 1,646,295 | - |
| 238 | AVIR | Atea Pharmaceuticals, Inc. | 411.45M | 0.59% | 253,263 | - |
| 239 | SPRY | ARS Pharmaceuticals, Inc. | 404.75M | -1.21% | 1,828,672 | 116.93M |
| 240 | EDIT | Editas Medicine, Inc. | 402.38M | 3.97% | 2,162,684 | 47.01M |
| 241 | TTRX | Turn Therapeutics Inc. | 397.07M | 0.15% | 136,296 | - |
| 242 | EIKN | Eikon Therapeutics, Inc. | 397.03M | -1.08% | 420,360 | - |
| 243 | ZURA | Zura Bio Limited | 393.86M | -0.72% | 2,953,605 | - |
| 244 | GALT | Galectin Therapeutics Inc. | 393.31M | 3.72% | 219,979 | - |
| 245 | KYTX | Kyverna Therapeutics, Inc. | 384.67M | -4.60% | 1,183,000 | - |
| 246 | RLMD | Relmada Therapeutics, Inc. | 384.01M | -1.64% | 1,209,546 | - |
| 247 | IRD | Opus Genetics, Inc. | 381.04M | 1.55% | 1,791,183 | 9.86M |
| 248 | VTVT | vTv Therapeutics Inc. | 379.83M | -4.02% | 18,014 | 36.84M |
| 249 | PRLD | Prelude Therapeutics Incorporated | 377.99M | -3.17% | 742,040 | 22.42M |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 377.47M | 0.93% | 748,000 | 65.26M |
| 251 | AGEN | Agenus Inc. | 376.37M | 0.36% | 1,085,594 | 132.69M |
| 252 | ARCT | Arcturus Therapeutics Holdings Inc. | 370.35M | -1.36% | 744,828 | 29.37M |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 364.15M | 3.63% | 434,445 | 1.00 |
| 254 | CCCC | C4 Therapeutics, Inc. | 362.92M | -6.05% | 3,384,918 | 35.04M |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 357.69M | -1.26% | 136,434 | 59.22M |
| 256 | OBIO | Orchestra BioMed Holdings, Inc. | 357.63M | -6.30% | 421,087 | 31.98M |
| 257 | OCGN | Ocugen, Inc. | 345.89M | 2.00% | 3,446,560 | 4.58M |
| 258 | SRZN | Surrozen, Inc. | 344.61M | -2.27% | 645,977 | 11.51M |
| 259 | CABA | Cabaletta Bio, Inc. | 339.09M | 5.82% | 5,705,539 | - |
| 260 | ARTV | Artiva Biotherapeutics, Inc. | 333.92M | 0.59% | 587,649 | 251.00K |
| 261 | SCTX | Scribe Therapeutics Inc. | 317.86M | -2.27% | 475,205 | 33.30M |
| 262 | INDP | Indaptus Therapeutics, Inc. | 317.12M | 12.26% | 568,113 | - |
| 263 | BNTC | Benitec Biopharma Inc. | 313.25M | -6.26% | 135,137 | - |
| 264 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 311.88M | -1.27% | 485,952 | - |
| 265 | LRMR | Larimar Therapeutics, Inc. | 308.97M | -3.27% | 834,959 | - |
| 266 | LXEO | Lexeo Therapeutics, Inc. | 289.61M | -2.49% | 2,592,074 | - |
| 267 | ABEO | Abeona Therapeutics Inc. | 287.64M | 0.40% | 1,213,609 | 25.52M |
| 268 | CUVL | Clinuvel Pharmaceuticals Limited | 283.89M | 6.54% | 761 | 65.05M |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 281.54M | 0.27% | 1,540,441 | 80.00M |
| 270 | RCKT | Rocket Pharmaceuticals, Inc. | 281.02M | -1.16% | 1,818,378 | - |
| 271 | XFOR | X4 Pharmaceuticals, Inc. | 280.59M | - | 911,390 | 15.85M |
| 272 | EYPT | EyePoint, Inc. | 280.19M | 0.62% | 3,108,728 | 2.79M |
| 273 | VNDA | Vanda Pharmaceuticals Inc. | 279.94M | -3.74% | 1,448,945 | 215.72M |
| 274 | FATE | Fate Therapeutics, Inc. | 277.98M | 0.87% | 658,023 | 6.49M |
| 275 | IPSC | Century Therapeutics, Inc. | 277.05M | -4.97% | 802,950 | 109.16M |
| 276 | UPB | Upstream Bio, Inc. | 276.05M | - | 956,519 | 3.16M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 271.14M | -2.61% | 415,751 | 114.70K |
| 278 | ACIU | AC Immune SA | 270.94M | -3.02% | 320,246 | 21.67M |
| 279 | VOGX | Vogenx, Inc. | 270.81M | -9.12% | 55,484 | - |
| 280 | IMRX | Immuneering Corporation | 263.32M | 0.99% | 588,814 | - |
| 281 | VCRE | Vicore Pharma Holding AB (publ) | 261.45M | -1.06% | 27,502 | 412.09K |
| 282 | PYXS | Pyxis Oncology, Inc. | 255.64M | -2.28% | 1,999,577 | 11.04M |
| 283 | STRO | Sutro Biopharma, Inc. | 254.52M | -3.88% | 371,474 | 45.70M |
| 284 | IFRX | InflaRx N.V. | 253.47M | 0.58% | 422,104 | -11.54K |
| 285 | EVMN | Evommune, Inc. | 251.14M | -4.02% | 1,745,474 | 10.00M |
| 286 | CAMP | Camp4 Therapeutics Corporation | 251.01M | 4.17% | 364,056 | 4.22M |
| 287 | PALI | Palisade Bio, Inc. | 250.95M | 0.70% | 1,996,075 | 500.00K |
| 288 | NAUT | Nautilus Biotechnology, Inc. | 249.42M | 24.84% | 14,189,801 | 190.00K |
| 289 | GLSI | Greenwich LifeSciences, Inc. | 249.24M | -2.13% | 175,416 | - |
| 290 | QTTB | Q32 Bio Inc. | 245.00M | -0.24% | 2,096,909 | 53.74M |
| 291 | IVVD | Invivyd, Inc. | 242.32M | 0.69% | 7,129,025 | 58.37M |
| 292 | ZNTL | Zentalis Pharmaceuticals, Inc. | 238.57M | -3.26% | 1,451,182 | 26.87M |
| 293 | BCYC | Bicycle Therapeutics plc | 236.58M | -5.06% | 728,618 | 61.21M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 235.73M | -1.37% | 35,955 | 1.80M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 235.28M | 2.89% | 1,249,310 | 13.08M |
| 296 | PRQR | ProQR Therapeutics N.V. | 230.73M | 0.31% | 622,636 | 21.05M |
| 297 | MGNX | MacroGenics, Inc. | 228.05M | -0.56% | 980,528 | 175.14M |
| 298 | LYEL | Lyell Immunopharma, Inc. | 227.41M | -1.38% | 111,390 | 27.00K |
| 299 | KROS | Keros Therapeutics, Inc. | 225.24M | 0.89% | 231,530 | 15.01M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 222.68M | 1.94% | 200,377 | 1.48M |
| 301 | SION | Sionna Therapeutics, Inc. | 221.99M | -3.73% | 1,160,169 | - |
| 302 | CGEN | Compugen Ltd. | 218.81M | -1.28% | 113,758 | 74.00M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 218.35M | 1.12% | 947,405 | 80.62M |
| 304 | ANTX | AN2 Therapeutics, Inc. | 215.47M | 1.60% | 451,282 | - |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 210.93M | -1.60% | 431,784 | 7.15M |
| 306 | YARW | Yarrow Bioscience, Inc. | 207.21M | -5.64% | 47,117 | - |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 202.54M | 2.26% | 973,162 | - |
| 308 | ALEC | Alector, Inc. | 202.10M | -2.69% | 1,170,910 | 13.86M |
| 309 | ACOG | Alpha Cognition Inc. | 198.18M | 4.60% | 193,411 | 15.26M |
| 310 | TRDA | Entrada Therapeutics, Inc. | 193.99M | -5.28% | 463,706 | 4.69M |
| 311 | NGEN | NervGen Pharma Corp. | 191.39M | 1.14% | 409,595 | - |
| 312 | ADAG | Adagene Inc. | 191.36M | -2.73% | 297,964 | 9.29M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 186.77M | 0.22% | 178,321 | 2.00M |
| 314 | CUE | Cue Biopharma, Inc. | 185.75M | 1.27% | 144,234 | 37.66M |
| 315 | NKTX | Nkarta, Inc. | 184.43M | 0.59% | 366,775 | - |
| 316 | MSLE | Satellos Bioscience Inc. | 180.00M | - | 27,484 | - |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 179.28M | 2.97% | 486,039 | 1.50M |
| 318 | CHRS | Coherus Oncology, Inc. | 179.22M | - | 1,183,114 | 50.94M |
| 319 | MDWD | MediWound Ltd. | 174.55M | -0.59% | 47,952 | 11.86M |
| 320 | DTIL | Precision BioSciences, Inc. | 174.17M | -0.32% | 292,951 | 45.06M |
| 321 | AVXL | Anavex Life Sciences Corp. | 168.71M | -3.70% | 1,989,710 | - |
| 322 | ALXO | ALX Oncology Holdings Inc. | 168.70M | -6.15% | 2,256,756 | - |
| 323 | MENS | Jyong Biotech Ltd. | 161.83M | 7.39% | 29,812 | - |
| 324 | VRXA | Veraxa Biotech AG | 159.79M | -5.04% | 150,231 | 29.54K |
| 325 | TARA | Protara Therapeutics, Inc. | 159.56M | -2.17% | 1,909,315 | - |
| 326 | PEPG | PepGen Inc. | 157.91M | 3.17% | 744,401 | - |
| 327 | NBP | NovaBridge Biosciences | 157.18M | 1.12% | 252,894 | - |
| 328 | NERV | Minerva Neurosciences, Inc. | 156.61M | 1.55% | 57,000 | - |
| 329 | CMPX | Compass Therapeutics, Inc. | 154.28M | -4.93% | 20,762,306 | 850.00K |
| 330 | MOLN | Molecular Partners AG | 153.82M | - | 12 | 856.30K |
| 331 | TNXP | Tonix Pharmaceuticals Holding Corp. | 152.82M | -3.47% | 803,104 | 29.10M |
| 332 | VYGR | Voyager Therapeutics, Inc. | 150.96M | -8.41% | 1,172,017 | 34.46M |
| 333 | CDXS | Codexis, Inc. | 148.93M | - | 551,850 | 77.68M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 147.53M | -1.45% | 580,517 | - |
| 335 | HUMA | Humacyte, Inc. | 144.87M | 3.70% | 5,395,403 | 2.12M |
| 336 | TLSA | Tiziana Life Sciences Ltd | 144.82M | -1.75% | 436,812 | - |
| 337 | OTLK | Outlook Therapeutics, Inc. | 144.36M | 3.13% | 5,619,583 | -1.16M |
| 338 | KRRO | Korro Bio, Inc. | 141.96M | -0.72% | 153,051 | 2.38M |
| 339 | IPHA | Innate Pharma S.A. | 138.78M | -2.52% | 87,639 | 11.21M |
| 340 | PMVP | PMV Pharmaceuticals, Inc. | 135.17M | 2.29% | 3,735,786 | - |
| 341 | RNA | Atrium Therapeutics, Inc. | 134.11M | -3.69% | 533,801 | 35.84M |
| 342 | SPRB | Spruce Biosciences, Inc. | 131.37M | 2.10% | 77,210 | 697.00K |
| 343 | ARMP | Armata Pharmaceuticals, Inc. | 130.88M | 6.34% | 108,844 | 5.54M |
| 344 | CRBU | Caribou Biosciences, Inc. | 130.79M | - | 866,390 | 10.04M |
| 345 | CBUS | Cibus, Inc. | 130.69M | 4.91% | 247,441 | 4.35M |
| 346 | ENGN | enGene Therapeutics Inc. | 130.01M | -2.02% | 692,748 | - |
| 347 | KZIA | Kazia Therapeutics Limited | 127.03M | -2.11% | 128,645 | 1.27M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 126.49M | -0.28% | 3,725,994 | 1.34M |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 125.68M | 1.93% | 612,965 | 3.39M |
| 350 | SEER | Seer, Inc. | 124.59M | 2.27% | 200,536 | 14.22M |
| 351 | HURA | TuHURA Biosciences, Inc. | 121.72M | -3.54% | 287,679 | - |
| 352 | FHTX | Foghorn Therapeutics Inc. | 119.96M | -30.82% | 2,546,614 | 36.74M |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 119.94M | -4.13% | 2,918,734 | 65.34K |
| 354 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 118.56M | -3.31% | 835,400 | - |
| 355 | UNCY | Unicycive Therapeutics, Inc. | 117.55M | -7.25% | 1,510,066 | - |
| 356 | GNLX | Genelux Corporation | 114.72M | 1.59% | 278,255 | 8.00K |
| 357 | MIST | Milestone Pharmaceuticals Inc. | 114.10M | -0.74% | 769,552 | 2.34M |
| 358 | TENX | Tenax Therapeutics, Inc. | 113.42M | 2.59% | 2,033,172 | - |
| 359 | RANI | Rani Therapeutics Holdings, Inc. | 113.02M | 1.92% | 418,512 | 4.88M |
| 360 | COYA | Coya Therapeutics, Inc. | 112.83M | 1.69% | 88,688 | 8.02M |
| 361 | LENZ | LENZ Therapeutics, Inc. | 112.48M | -5.54% | 1,126,914 | 21.48M |
| 362 | VANI | Vivani Medical, Inc. | 110.95M | 0.82% | 88,201 | - |
| 363 | TVGN | Tevogen Inc. | 109.84M | 3.87% | 1,618 | - |
| 364 | AARD | Aardvark Therapeutics, Inc. | 109.21M | -5.31% | 147,530 | - |
| 365 | IMUX | Immunic, Inc. | 108.61M | -7.87% | 723,243 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 108.59M | 0.53% | 472,266 | 70.00M |
| 367 | PYPD | PolyPid Ltd. | 105.42M | -3.35% | 168,309 | - |
| 368 | PLYX | Polaryx Therapeutics, Inc. | 103.68M | 2.97% | 18,662 | - |
| 369 | OKUR | OnKure Therapeutics, Inc. | 103.67M | 0.79% | 526,929 | - |
| 370 | CLLS | Cellectis S.A. | 102.60M | 2.14% | 46,802 | 63.82M |
| 371 | ANIX | Anixa Biosciences, Inc. | 102.55M | 6.50% | 434,484 | - |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 95.16M | 12.06% | 85,748 | 6.19M |
| 373 | NMRA | Neumora Therapeutics, Inc. | 93.93M | -9.11% | 2,691,260 | - |
| 374 | BMEA | Biomea Fusion, Inc. | 92.05M | -2.31% | 844,333 | - |
| 375 | RLYB | Rallybio Corporation | 90.86M | 2.09% | 7,037 | 646.00K |
| 376 | EQ | Equillium, Inc. | 89.41M | -8.44% | 934,793 | 4.39M |
| 377 | NRXS | NeurAxis, Inc. | 89.29M | -0.84% | 47,408 | 5.32M |
| 378 | ICCC | ImmuCell Corporation | 88.55M | 1.56% | 5,806 | 30.68M |
| 379 | NTRB | Nutriband Inc. | 88.49M | -1.09% | 42,323 | 1.62M |
| 380 | CGTX | Cognition Therapeutics, Inc. | 87.97M | 3.80% | 244,547 | - |
| 381 | MNOV | MediciNova, Inc. | 87.61M | 9.20% | 275,013 | 920.48K |
| 382 | CNXU | Conexeu Sciences Inc. | 87.44M | -6.63% | 115,746 | - |
| 383 | CRDF | Cardiff Oncology, Inc. | 87.13M | -5.08% | 628,341 | 508.00K |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 85.28M | -1.00% | 205,101 | - |
| 385 | PMN | ProMIS Neurosciences, Inc. | 84.30M | 0.21% | 27,803 | - |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 81.15M | 0.85% | 76,075 | - |
| 387 | ONCY | Oncolytics Biotech Inc. | 80.46M | -1.59% | 611,814 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 78.87M | 1.23% | 22,028 | 43.30M |
| 389 | OKYO | OKYO Pharma Limited | 77.14M | 9.70% | 82,517 | - |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 75.24M | -2.99% | 44,712 | 30.32M |
| 391 | OSTX | OS Therapies Incorporated | 74.72M | 0.62% | 233,394 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 74.63M | -0.58% | 386,093 | - |
| 393 | NTHI | NeOnc Technologies Holdings, Inc. | 74.32M | -2.29% | 234,927 | 39.99K |
| 394 | MAIA | MAIA Biotechnology, Inc. | 72.38M | 1.71% | 405,026 | - |
| 395 | IBIO | iBio, Inc. | 72.35M | 1.35% | 534,394 | 100.00K |
| 396 | RNXT | RenovoRx, Inc. | 71.30M | 1.94% | 269,359 | 1.98M |
| 397 | ALDX | Aldeyra Therapeutics, Inc. | 70.58M | -9.30% | 2,278,805 | - |
| 398 | ACET | Adicet Bio, Inc. | 69.97M | -2.11% | 164,975 | - |
| 399 | SPRO | Spero Therapeutics, Inc. | 69.30M | -5.56% | 906,913 | 47.00M |
| 400 | CING | Cingulate Inc. | 69.22M | 0.21% | 41,085 | - |
| 401 | RNTX | Rein Therapeutics Inc. | 69.07M | -6.03% | 480,862 | - |
| 402 | CSBR | Champions Oncology, Inc. | 68.76M | 1.23% | 3,513 | 60.66M |
| 403 | FBIO | Fortress Biotech, Inc. | 67.70M | -1.93% | 327,172 | 68.47M |
| 404 | XBIT | XBiotech Inc. | 66.77M | -0.45% | 24,016 | - |
| 405 | HRTX | Heron Therapeutics, Inc. | 65.99M | -2.33% | 4,078,353 | 151.18M |
| 406 | ALPS | Alps Group Inc | 65.73M | 1.28% | 14,693 | 3.74M |
| 407 | GOSS | Gossamer Bio, Inc. | 65.44M | -2.01% | 235,518 | 53.29M |
| 408 | GUTS | Fractyl Health, Inc. | 64.72M | -9.66% | 3,057,782 | 3.00K |
| 409 | KLRS | Kalaris Therapeutics, Inc. | 64.27M | -5.26% | 235,896 | - |
| 410 | PLRX | Pliant Therapeutics, Inc. | 64.09M | -1.43% | 402,810 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 63.48M | -2.28% | 48,968 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 63.13M | 0.75% | 96,138 | 11.57M |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 62.61M | -1.27% | 17,669 | - |
| 414 | MREO | Mereo BioPharma Group plc | 60.65M | 3.52% | 880,441 | 500.00K |
| 415 | BOLD | Boundless Bio, Inc. | 59.60M | 1.16% | 111,342 | - |
| 416 | XLO | Xilio Therapeutics, Inc. | 59.29M | 1.12% | 7,400 | 64.09M |
| 417 | CNTB | Connect Biopharma Holdings Limited | 58.38M | -5.38% | 4,196,071 | 2.95M |
| 418 | ATHE | Alterity Therapeutics Limited | 58.29M | -1.15% | 47,167 | 2.50M |
| 419 | CLNN | Clene Inc. | 57.99M | 1.49% | 61,480 | 197.00K |
| 420 | HYPD | Hyperion DeFi, Inc. | 57.96M | 1.91% | 534,396 | 1.40M |
| 421 | INMB | INmune Bio Inc. | 53.56M | - | 282,448 | 50.00K |
| 422 | EXOZ | eXoZymes, Inc. | 53.55M | 0.17% | 2,116 | -700.00 |
| 423 | IMA | ImageneBio, Inc. | 52.22M | 0.44% | 7,832 | 800.00K |
| 424 | EDSA | Edesa Biotech, Inc. | 52.15M | -3.74% | 18,435 | - |
| 425 | CELU | Celularity Inc. | 51.92M | 15.94% | 221,837 | 18.97M |
| 426 | APLM | Apollomics, Inc. | 51.63M | 1.03% | 401 | 8.84M |
| 427 | ELTX | Elicio Therapeutics, Inc. | 50.46M | - | 175,912 | - |
| 428 | ANVS | Annovis Bio, Inc. | 50.28M | 0.85% | 648,536 | - |
| 429 | SER | Serina Therapeutics, Inc. | 49.78M | 0.51% | 11,967 | 130.00K |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 49.63M | 2.10% | 71,023 | - |
| 431 | TIL | Instil Bio, Inc. | 49.03M | -0.14% | 27,943 | - |
| 432 | BSEM | BioStem Technologies, Inc. | 48.73M | -11.07% | 151,852 | 34.59M |
| 433 | CRVO | CervoMed Inc. | 45.66M | 3.07% | 218,197 | 331.30K |
| 434 | IBO | Impact BioMedical Inc. | 45.45M | -2.02% | 11,554 | 35.00K |
| 435 | LONA | LeonaBio, Inc. | 45.41M | 10.05% | 332,360 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 45.10M | 5.29% | 471,304 | 21.00M |
| 437 | FLNA | Filana Therapeutics, Inc. | 44.97M | -3.53% | 1,691,150 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 43.54M | 1.47% | 105,029 | - |
| 439 | VERU | Veru Inc. | 42.80M | -1.18% | 104,923 | 16.89M |
| 440 | LITS | Lite Strategy, Inc. | 41.96M | 0.36% | 1,012,764 | - |
| 441 | PDSB | PDS Biotechnology Corporation | 41.89M | 6.00% | 3,656,770 | - |
| 442 | CVM | CEL-SCI Corporation | 40.63M | 10.53% | 395,180 | - |
| 443 | MGX | Metagenomi Therapeutics, Inc. | 38.53M | -7.69% | 110,872 | 13.56M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | 1.74% | 81,800 | 35.09M |
| 445 | BCTX | BriaCell Therapeutics Corp. | 35.09M | -1.70% | 104,915 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 34.59M | 0.73% | 28,977 | 31.52M |
| 447 | IMMP | Immutep Limited | 32.78M | -4.19% | 48,636 | 13.79M |
| 448 | NNVC | NanoViricides, Inc. | 32.67M | 1.59% | 239,612 | - |
| 449 | BYSI | BeyondSpring Inc. | 32.37M | -3.24% | 77,074 | 1.88M |
| 450 | QNCX | Quince Therapeutics, Inc. | 29.70M | -4.82% | 66,982 | - |
| 451 | MCRB | Seres Therapeutics, Inc. | 29.23M | 0.34% | 100,953 | 1.88M |
| 452 | CNTX | Context Therapeutics Inc. | 28.45M | -1.49% | 332,646 | - |
| 453 | IGC | IGC Pharma, Inc. | 28.42M | 1.81% | 633,240 | 1.11M |
| 454 | ATYR | aTyr Pharma, Inc. | 28.17M | -2.35% | 1,980,686 | 190.00K |
| 455 | QNTM | Quantum BioPharma Ltd. | 27.82M | 0.44% | 79,206 | - |
| 456 | GRDX | GridAI Technologies Corp. | 26.98M | 10.76% | 107,272 | - |
| 457 | EVAX | Evaxion A/S | 26.69M | 0.63% | 33,886 | 7.49M |
| 458 | RNAZ | TransCode Therapeutics, Inc. | 26.58M | 1.62% | 15,458 | - |
| 459 | ABVC | ABVC BioPharma, Inc. | 26.18M | -0.98% | 98,683 | 797.92K |
| 460 | KYNB | Kyntra Bio, Inc. | 25.55M | -2.92% | 26,079 | 4.62M |
| 461 | ATOS | Atossa Therapeutics, Inc. | 23.35M | 3.08% | 74,265 | - |
| 462 | PLRZ | Polyrizon Ltd. | 23.34M | -6.88% | 56,326 | - |
| 463 | NXTC | NextCure, Inc. | 23.30M | 2.62% | 63,325 | - |
| 464 | COCP | Cocrystal Pharma, Inc. | 22.06M | 0.44% | 12,039 | 330.00K |
| 465 | TCRX | TScan Therapeutics, Inc. | 21.72M | 0.94% | 151,983 | 7.11M |
| 466 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.47M | -5.30% | 20,292 | - |
| 467 | RADX | Radiopharm Theranostics Limited | 21.10M | -4.05% | 62,317 | 9.34M |
| 468 | ICU | SeaStar Medical Holding Corporation | 20.67M | 25.07% | 518,687 | 1.71M |
| 469 | ESLA | Estrella Immunopharma, Inc. | 20.36M | -1.47% | 14,484 | - |
| 470 | PBM | Psyence Biomedical Ltd. | 19.68M | -5.84% | 75,113 | - |
| 471 | ACTU | Actuate Therapeutics, Inc. | 19.67M | -7.89% | 96,149 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 18.81M | -5.48% | 237,386 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 18.78M | -1.14% | 12,581 | 1.17M |
| 474 | KPTI | Karyopharm Therapeutics Inc. | 18.20M | -7.45% | 2,341,257 | 146.62M |
| 475 | MRKR | Marker Therapeutics, Inc. | 17.51M | - | 100,289 | 3.55M |
| 476 | PTN | Palatin Technologies, Inc. | 17.01M | 3.04% | 14,280 | 13.19M |
| 477 | AKTX | Akari Therapeutics, Plc | 16.98M | -1.36% | 13,480 | - |
| 478 | LPCN | Lipocine Inc. | 16.90M | -0.97% | 38,941 | 1.57M |
| 479 | CLRB | Cellectar Biosciences, Inc. | 16.82M | -4.81% | 48,039 | - |
| 480 | DYAI | Dyadic International, Inc. | 16.61M | 6.10% | 142,156 | 3.80M |
| 481 | ALLR | Allarity Therapeutics, Inc. | 16.55M | - | 28,865 | 345.00K |
| 482 | NCEL | NewcelX Ltd. | 16.46M | -2.06% | 2,972 | - |
| 483 | KPRX | Kiora Pharmaceuticals, Inc. | 16.24M | -1.10% | 3,345 | 20.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 15.91M | -2.68% | 59,210 | - |
| 485 | BCDA | BioCardia, Inc. | 15.82M | 2.45% | 42,833 | 3.00K |
| 486 | TVRD | Tvardi Therapeutics, Inc. | 15.34M | -7.26% | 313,802 | - |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 14.59M | -1.59% | 80,504 | 7.11M |
| 488 | AEON | AEON Biopharma, Inc. | 13.92M | -3.79% | 3,233,667 | - |
| 489 | INAB | IN8bio, Inc. | 13.80M | - | 17,505 | - |
| 490 | NIKI | Niki BioSolutions, Inc. | 13.52M | -4.37% | 11,100 | - |
| 491 | TPST | Tempest Therapeutics, Inc. | 13.42M | 0.63% | 2,273,800 | - |
| 492 | HIND | Vyome Holdings, Inc. | 13.41M | -0.52% | 20,222 | 129.73K |
| 493 | PASG | Passage Bio, Inc. | 13.29M | -1.69% | 15,725 | - |
| 494 | LSTA | Lisata Therapeutics, Inc. | 13.25M | -1.34% | 3,653 | 100.00K |
| 495 | DARE | Daré Bioscience, Inc. | 12.89M | -0.96% | 148,395 | 1.37M |
| 496 | BLRX | BioLineRx Ltd. | 12.59M | 0.85% | 3,126 | 1.39M |
| 497 | VTGN | Vistagen Therapeutics, Inc. | 12.47M | -0.57% | 1,102,281 | 2.50M |
| 498 | PLUR | Pluri Inc. | 12.47M | - | 3,384 | 1.02M |
| 499 | CNSY | Cerenome, Inc. | 12.14M | -10.11% | 234,618 | 4.20M |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 11.44M | -1.49% | 54,209 | - |